LicianPro

Outlook Therapeutics, Inc. ·

OTLK 8-K 2026-09-30

Outlook Therapeutics, Inc. (OTLK) 8-K dated 2026-09-30 — accession 0001104659-26-112356.

Outlook Therapeutics, Inc. (OTLK) is a biotechnology company listed on US.

Outlook Therapeutics, Inc. filed a 8-K on 2026-09-30. Accession 0001104659-26-112356.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported OTLK revenue for 2025-06-30 was $1.5M. Net income was -$20.2M. OTLK currently screens at market cap $68.6M.

Not investment advice. The OTLK SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr